Back
Cartesian Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer6.jpg)
The Biggest Financial Event of 2024?
Click here to find out.
Sell
25
RNAC
Cartesian Therapeutics
Last Price:
12.91
Seasonality Move:
-10.23%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer19.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
Cartesian Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.85 | Sell |
20-day SMA: | 13.88 | Sell |
50-day SMA: | 16.01 | Sell |
200-day SMA: | 21.37 | Sell |
8-day EMA: | 13.69 | Sell |
20-day EMA: | 14.18 | Sell |
50-day EMA: | 16.35 | Sell |
200-day EMA: | 22.22 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 40.66 | Sell |
Chaikin Money Flow: | -40444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.28 - 14.54) | Sell |
Bollinger Bands (100): | (14.39 - 27.07) | Sell |
Cartesian Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 12.98 while RNAC 8-day simple moving average is 13.85, which is a Sell signal.
- The stock price of RNAC is 12.98 while Cartesian Therapeutics 20-day SMA is 13.88, which makes it a Sell.
- Cartesian Therapeutics 50-day simple moving average is 16.01 while RNAC share price is 12.98, making it a Sell technically.
- RNAC stock price is 12.98 and Cartesian Therapeutics 200-day simple moving average is 21.37, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
25
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a Sell
The current Cartesian Therapeutics [RNAC] share price is $12.98. The Score for RNAC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
277.54M
Price in USD:
12.98
Share Volume:
53.5K
Cartesian Therapeutics 52-Week Range
52-Week High:
42.60
52-Week Low:
11.67
Sell
25
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?
The Cartesian Therapeutics stock price is 12.98 USD today. -
Will RNAC stock go up or go down?
Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cartesian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 12.98 while RNAC 8-day exponential moving average is 13.69, which is a Sell signal.
- The stock price of RNAC is 12.98 while Cartesian Therapeutics 20-day EMA is 14.18, which makes it a Sell.
- Cartesian Therapeutics 50-day exponential moving average is 16.35 while RNAC share price is 12.98, making it a Sell technically.
- RNAC stock price is 12.98 and Cartesian Therapeutics 200-day simple moving average is 22.22, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
- RNAC Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting Cartesian Therapeutics is a Sell
- Cartesian Therapeutics Relative Strength Index (RSI) is 40.66, which suggest Cartesian Therapeutics is oversold
- The Bollinger Bands (25) for Cartesian Therapeutics is (13.28 - 14.54), which suggest Cartesian Therapeutics is a Sell
- The Bollinger Bands (100) for Cartesian Therapeutics is (14.39 - 27.07), which suggest Cartesian Therapeutics is a Sell
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.